Informação da revista
Estatísticas
Siga este link para acessar o texto completo do artigo
Original Article
Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria
Fikriye Kalkan
, Sait Yeşillik, Fevzi Demirel, Ezgi Sönmez, Yasemin Balaban, Mustafa İlker İnan, Özgür Kartal
Autor para correspondência
Department of Immunology and Allergy, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey